Subcutaneous granulomas in the face
Conditions
Interventions
Experimental group:The subcutaneous granulomas on one side of the face were treated with medicine injection guided by the existing ultrasound instrument (Philips EPIQ7) at 15 MHz in the hospital.
Control group:There is no ultrasound guidance on the other side of the face, and medication is directly injected into the subcutaneous granuloma on the face.
Sponsors
The First Medical Center of Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with subcutaneous foreign body granulomas after injection of fillers in the same part on both sides of the face. 2. Patients who voluntarily accept treatment and cooperate with follow-up. 3.18<=Patient age<=65, no underlying diseases, able to score clearly according to the rating scale, good language skills, able to clearly express treatment satisfaction, and have the ability to act and sign informed consent patients
Exclusion criteria
Exclusion criteria: 1. Patients with a history of active infection or viral infection in the treatment area 2. Patients with active medical diseases 3. Patients who are using anticoagulant drugs and antiplatelet drugs 4. Patients who are unable to score clearly according to the rating scale, language or thinking disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Granuloma volume change; | — |
Countries
China
Contacts
Public ContactYoubai Chen
The First Medical Center of Chinese PLA General Hospital
Outcome results
None listed